ISIS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash and cash equivalents divide by its debt. ISIS Pharmaceuticals Inc's cash to debt ratio for the quarter that ended in Jun. 2015 was 1.75.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, ISIS Pharmaceuticals Inc could pay off its debt using the cash in hand for the quarter that ended in Jun. 2015.
During the past 13 years, ISIS Pharmaceuticals Inc's highest Cash to Debt Ratio was 4.87. The lowest was 0.24. And the median was 1.42.
This is the ratio of a company's Cash and cash equivalents to its debt. The debt includes the Current Portion of Long-Term Debt and Long-Term Debt. This ratio measures the financial strength of a company. This ratio is updated quarterly.
ISIS Pharmaceuticals Inc's Cash to Debt Ratio for the fiscal year that ended in Mar. 2014 is calculated as:
Do not have enough data to calculate Cash to Debt ratio.
ISIS Pharmaceuticals Inc's Cash to Debt Ratio for the quarter that ended in Jun. 2015 is calculated as:
|Cash to Debt Ratio||=||Cash and Cash Equivalents||/||Total Debt|
|=||Cash and Cash Equivalents||/||(Short-Term Debt||+||Long-Term Debt)|
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
ISIS Pharmaceuticals Inc Annual Data
ISIS Pharmaceuticals Inc Quarterly Data